Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), David Hung, M.D., Chief Executive Officer of Nuvation Bio Inc. (the “Company”), and Jennifer Fox, Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:
Dated: February 28, 2022
IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 28th day of February, 2022.
|
|
|
/s/ David Hung, M.D.
|
| /s/ Jennifer Fox
|
David Hung, M.D. |
| Jennifer Fox |
Chief Executive Officer |
| Chief Financial Officer |
This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Nuvation Bio Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date hereof), irrespective of any general incorporation language contained in such filing.